As Pharmacare legislation draws closer, CEO Sandra Hanna and SVP Shelita Dattani will discussed the nuanced terminology in the pharmacare conversation and why interpretation matters, while drawing connections between ongoing dialogues of pharmacare policy, drug shortages strategies and sustainable healthcare services.
